Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. - Wikidata - awgldk - TriplyDB

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

http://www.wikidata.org/entity/Q30227081

about

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes A highly conserved neutralizing epitope on group 2 influenza A viruses B Cells and Functional Antibody Responses to Combat Influenza Advances in structure-based vaccine design Influenza virus hemagglutinin stalk-based antibodies and vaccines Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing Advancements in the development of subunit influenza vaccines Broadly neutralizing antibodies against influenza virus and prospects for universal therapies Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection Two years after pandemic influenza A/2009/H1N1: what have we learned?Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.New vaccines against influenza virus.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses Universal influenza vaccines, a dream to be realized soon.Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.Continuing challenges in influenza.Advances in influenza vaccination.Adenoviral vectors as novel vaccines for influenza.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Novel universal influenza virus vaccine approaches Stalking influenza by vaccination with pre-fusion headless HA mini-stem Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza Cross-protective immunity to influenza A viruses.Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus Advances in the development of universal influenza vaccines.Virus-like particles as universal influenza vaccines Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.

P2860

Q24614628-BF45D494-4A2F-4C0C-BB38-1281274509D5 Q24630467-30B1EC2F-FEBB-4421-802B-7709E95AEFAE Q26801639-0AB36CC8-E8BD-4F89-97E6-C48ECFC9D98E Q26824545-3C4F964D-D4FE-4C13-90C2-426842527988 Q27001190-0205F92A-E9EF-4949-AA76-AAA73F845FE8 Q27003874-5CC35A77-6A15-48A5-92BB-655EA538A133 Q27010100-B301D006-F585-4E7D-AFAE-C82668FE17D2 Q27010503-3727C4FC-68FF-4803-ACBC-4D0F62115F41 Q27676658-0B539244-F0C8-4F4C-BC18-89CC95A8A3C5 Q27677191-4E12D0CB-4FFC-48F8-AF56-AE2B5E352F95 Q28478448-716164A9-B0E0-4FE9-8F4C-ABFF3F26452C Q28539672-0F728939-845F-490D-853D-39A441007177 Q30209769-572D6151-08B0-4367-BBAA-EAACB39602F3 Q30224656-FBE7FA7C-CBA9-4022-9577-6B578F72AA20 Q30356933-5D49AC66-39CE-42D3-A866-AAB6F69C424D Q30357665-701C1A51-6471-4CBF-8528-C0F8AB3D3F04 Q30357932-1FDED1E3-8722-42FA-9126-A9FA6C89433B Q30358388-94D7C742-BAFC-48A3-99E0-E8CF0D2C4B84 Q30358935-72C0F179-9B46-44FD-9A62-46DD64F71C9F Q30361950-723CB194-6870-4976-B2FE-2526DB390F30 Q30362744-92933B5A-6949-468E-91E8-33C0D2D26A30 Q30363190-F6ECF77B-6A2C-4DD2-B63F-2BA52DB9E1B2 Q30364315-1CFE7C95-934B-4291-BFEB-32C65F982A2C Q30370445-95C08B81-114D-4CF9-B097-120C925C01AB Q30372274-D699CDF4-C255-4F2A-8655-A2FCC00FB468 Q30372667-B13D311C-55BD-4AC5-9469-85817FF45DC0 Q30374768-B5588320-659C-4721-BC56-4EFF059884D3 Q30375268-336EAD80-D818-4A9F-8869-664C1E00C2F2 Q30376605-3E721BD1-55CE-48ED-AE1D-A52E1BE3F78D Q30376724-77FF94D4-3841-4F53-A0FF-93945A97A39B Q30385071-BCA7AF02-4F5B-445A-9F55-134B30BCF1EC Q30385331-41559E5A-E3B2-45EC-A9E2-E457D95EA29F Q30386196-6372DDA4-B5C4-4EB7-8AB9-E8114765DC9C Q30389700-4CE05529-1292-4BA7-B2BB-9F382BF1CB4D Q30396399-F4A2F482-B168-4594-A1DA-B50B5A8E2240 Q30400817-0BC64A99-9F62-490B-9F88-E15205D6706C Q30420210-B0D2C8FE-7276-4C3E-97D7-6BB03C80A131 Q30421502-B3DDB3F2-2BF3-49DB-A2A8-74640EDABE4A Q30421558-2B798831-4940-4CD3-A8FD-E36B9C210AB8 Q30421687-EB5E8F87-343B-4263-83BD-BE223BE1B485

P2860

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

http://www.wikidata.org/entity/Q30227081

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@ast

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@en

type

label

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@ast

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@en

prefLabel

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@ast

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@en

P1433

Q30227081-A0887917-060A-4724-86E3-EA65500D92F2

P1476

Q30227081-FA4CB2F5-A4AD-4FE0-BA80-F695C77BAAFE

P2093

Q30227081-24093047-A5A9-4D7D-ACA4-07EF2FF6DA78

Q30227081-45B1CA1E-1487-430E-801D-BA2CDE239206

Q30227081-7C317B35-84CE-4D10-AE1E-CED13506F843

Q30227081-85B3FE91-F2A2-4508-849A-66F781CA0645

Q30227081-AD3E7E25-BDAB-49F2-9643-A57E327260F0

Q30227081-BA1071D4-5030-40D8-9A45-F26D57BADBE0

Q30227081-BDB76A7E-8393-4D3D-9571-D505D7A4B6AB

Q30227081-C0C973DE-38C3-4DCD-A448-86B5DF321975

Q30227081-D31563C9-75E0-4C7B-B7CC-1D492061D76C

Q30227081-D82599B9-E7E2-4401-B03A-1C6B301962E2

P2860

Q30227081-0E98BBB8-AA6C-46B4-8F74-A6282B1ECDFF

Q30227081-15AEA41D-20D6-4081-9220-9BC9A2A4D602

Q30227081-1966600D-CB38-48EA-9F49-AD6C8FAF673C

Q30227081-2045BEB9-868F-4958-80FE-183D0F70EA3C

Q30227081-2695A3CB-4BB6-4C17-AF33-1A3BE48ECFAC

Q30227081-27DC61E7-E599-405E-B730-C81FC2384275

Q30227081-33140114-380A-42EE-AF64-32D7170909DF

Q30227081-349301AD-4880-4566-93DF-57381A31AF00

Q30227081-366261A6-5725-437F-9D53-8050300E7F34

Q30227081-38E00C0D-30B4-46C4-AA36-CAF3D4578225

P304

Q30227081-7FF2C1F9-D8F5-4955-B298-236B3DB333D2

P31

Q30227081-42973188-B14A-4CB5-B917-AE1A36A0FBA4

P356

Q30227081-5FD3BF79-B9EE-4254-AB3B-0916F1682903

P407

Q30227081-2C5C7D5A-3065-4D53-AEAA-1814D6E6562A

P433

Q30227081-BE2E9F74-02A0-4BF7-84FB-F5AE2C740575

P478

Q30227081-7BC7EED7-49C9-46E7-B5CC-7C4C0C2A3E88

P577

Q30227081-5CA800CF-BBB6-4BD1-8B60-A0E7A68B6FF3

P5875

Q30227081-7F14662E-1998-4801-957D-DE659E796F07

P698

Q30227081-D8B81015-F63C-4570-AEE4-B8A3088F9F43

P921

Q30227081-373AB702-D71B-47C0-B150-CE59E6929306

P932

Q30227081-7F9ED8B8-ABA9-4C6E-A7A8-E2529F919725

P356

PNAS.1007465107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Design of an HA2-based Escheri ...... ice from pathogenic challenge.

@en

P2093

Cheryl Callahan

http://www.w3.org/2001/XMLSchema#string

Danilo R Casimiro

http://www.w3.org/2001/XMLSchema#string

Gayathri Bommakanti

http://www.w3.org/2001/XMLSchema#string

Gwendolyn J Heidecker

http://www.w3.org/2001/XMLSchema#string

Jan ter Meulen

http://www.w3.org/2001/XMLSchema#string

John W Shiver

http://www.w3.org/2001/XMLSchema#string

Joseph G Joyce

http://www.w3.org/2001/XMLSchema#string

Michael P Citron

http://www.w3.org/2001/XMLSchema#string

Raghavan Varadarajan

http://www.w3.org/2001/XMLSchema#string

Robert W Hepler

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Design of a Novel Globular Protein Fold with Atomic-Level Accuracy

Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography

Structure of influenza haemagglutinin at the pH of membrane fusion

Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation

The interpretation of protein structures: estimation of static accessibility

P304

13701-13706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1007465107

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113533

http://www.w3.org/2001/XMLSchema#string

P698

20615991

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

2922242

http://www.w3.org/2001/XMLSchema#string